This month Forbes notes an interesting up-side for clinical development coming out of a down economy – individuals feeling a pinch in their wallets increasingly interested in participating in paid studies.
Guiding drug development along the treacherous path toward the future
By Craig Lipset
This month Forbes notes an interesting up-side for clinical development coming out of a down economy – individuals feeling a pinch in their wallets increasingly interested in participating in paid studies.
0 comments:
Post a Comment